The Endgame Illusion - When Moral Certainty Replaces Policy Reality

https://ash.org/making-endgame-inevitable/

The Tobacco Endgame Report presents itself as bold, visionary and morally urgent. It begins with a statistic no one disputes: millions die each year from smoking. That devastation is real. But from that premise, the report makes a leap that deserves much more scrutiny than it receives. It shifts from reducing smoking to eliminating the entire tobacco and nicotine industry as an inevitability. That transition is not evidence-based policy analysis. It is moral framing presented as destiny.

The most revealing aspect of the report is not its statistics about harm, but its communications strategy. Much of the document is not about epidemiology, behavioural science or regulatory economics. It is about narrative control. It advises advocates to normalise the concept of elimination, to avoid language that sounds radical, to lead with public support figures and to frame policies in ways that concentrate blame on “industry power.” It encourages cohesion in messaging and warns against inconsistent definitions. In other words, it is less a scientific roadmap and more a political playbook.

That is not inherently illegitimate. Advocacy always involves persuasion. But it becomes problematic when persuasion substitutes for grappling with complexity. The report treats elimination as a technical problem of political will rather than as a behavioural, economic and social problem involving millions of adults who currently consume nicotine. It assumes that if governments are sufficiently coordinated and messaging sufficiently disciplined, the industry will collapse. Yet demand does not dissolve simply because supply is legislated away.

History across multiple psychoactive products shows that strong, persistent demand combined with restrictive legal supply adapts. Sometimes that adaptation is corporate innovation. Sometimes it is a black market. Often it is both. The report acknowledges that the industry behaves like a Hydra, pivoting to new products. But it treats this as a communications challenge rather than a structural market reality. If nicotine demand persists, something will meet it. Eliminating formal industry actors does not eliminate consumer appetite.

Another central flaw is the conflation of combustible cigarettes with all nicotine products. The report’s strategic guidance explicitly recommends positioning the endgame as targeting all nicotine products. That framing collapses a critical distinction between combustion and non-combustion. Cigarettes kill primarily because of the smoke and the products of combustion. Alternative nicotine delivery systems do not carry identical risk profiles. Yet in the endgame framing, nuance is treated as a dilution of the moral message.

This is a serious problem. Public health credibility rests on proportionality. When radically different risk products are rhetorically grouped, trust erodes. Harm reduction exists precisely because eliminating use is not always feasible in the short or medium term. If the objective is to reduce premature death, replacing higher-risk behaviour with substantially lower-risk behaviour can deliver measurable gains. The report largely bypasses this trade-off by insisting that any nicotine market, regardless of delivery method, perpetuates addiction and therefore must be extinguished.

The tone of inevitability is also troubling. “Tobacco industry elimination is inevitable” is not an empirical statement. It is aspirational rhetoric. Public policy does not move in straight lines toward moral destiny. It is contested, reversible and shaped by electoral cycles. We have already seen ambitious endgame laws modified or repealed in democratic systems. That does not invalidate long-term aspirations, but it does demonstrate that inevitability is not a serious analytical category.

The report leans heavily on polling data suggesting strong public support for phasing out cigarettes. But survey responses are highly sensitive to framing and rarely capture downstream consequences. Support for eliminating a harmful product in theory does not necessarily translate into support for enforcement strategies, penalties, fiscal implications or unintended market shifts in practice. Policy durability requires more than headline approval percentages.

There is also a deeper philosophical shift embedded in the document. Traditional tobacco control aimed to reduce harm through taxation, marketing restrictions, smoke-free environments and cessation support. The endgame reframes the mission as eliminating an industry actor. That shift carries risks. When policy becomes centred on eliminating a villain rather than managing a behaviour, dissent can be framed as moral compromise rather than legitimate debate about proportionality and outcomes.

The report’s messaging advice underscores this risk. It encourages advocates to lead with evidence of overwhelming support and to frame each policy by how it eliminates industry power. That strategic focus may energise campaigners, but it also narrows the space for pluralism. Public health thrives when it tolerates disagreement and adjusts to evidence. It becomes brittle when it treats elimination as the only morally coherent position.

None of this denies the toll of smoking. Seven million deaths annually is catastrophic. But seriousness about harm requires seriousness about human behaviour. Millions of adults use nicotine. Some will quit. Some will not. Some will switch products. Some will seek an illicit supply if the legal supply disappears. A credible policy discussion must incorporate these behavioural responses rather than assume they can be overridden by communications discipline.

The endgame concept may be rhetorically powerful. It may even function as a long-term aspiration. But presenting elimination as inevitable without deeply addressing demand persistence, substitution effects, black market incentives, risk differentials between products, and democratic reversibility is not rigorous policy analysis. It is moral ambition translated into political strategy.

If public health wants to maintain credibility in an era of scepticism, it must resist the temptation to substitute narrative certainty for empirical humility. Reducing smoking remains a vital goal. But eliminating an entire industry is not the same as eliminating harm. Confusing those two objectives may ultimately undermine both.